Akari Therapeutics Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| MMCAP INTERNATIONAL INC. SPC | 08/14/2026 | 100.00 K | $1.02 M | 100.00% | 5.58% |
| CRESSET ASSET MANAGEMENT, LLC | 08/14/2026 | 20.56 K | $210.65 K | 0.00% | 1.15% |
| JANE STREET GROUP, LLC | 08/14/2026 | 15.46 K | $158.42 K | 100.00% | 0.86% |
| HRT FINANCIAL LP | 08/14/2026 | 13.75 K | $140.00 K | 100.00% | 0.77% |
| CITADEL ADVISORS LLC | 09/02/2026 | 10.00 K | $102.45 K | 100.00% | 0.56% |
| IFP ADVISORS, INC | 07/20/2026 | 181 | $1.85 K | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 07/23/2026 | 14 | $143 | 180.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 08/05/2026 | 8 | $82 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 08/12/2026 | 7 | $72 | 100.00% | 0.00% |
| TRUVESTMENTS CAPITAL LLC | 08/12/2026 | 1 | $10 | 0.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| IFP ADVISORS, INC | 07/20/2026 | 0 | $0 | -100.00% | 0.00% |
Akari Therapeutics Plc institutional Ownership - FAQ's
During the previous two years, 14 institutional investors and hedge funds held shares of Akari Therapeutics Plc. The most heavily invested institutionals were:
MMCAP International Inc. SPC: 100,000
Cresset Asset Management, LLC: 20,561
JANE STREET GROUP, LLC: 15,463
HRT FINANCIAL LP: 13,745
IFP Advisors, Inc: 181
SBI Securities Co., Ltd.: 14
8.37% of Akari Therapeutics Plc stock is owned by institutional investors.
Institutional investors have bought a total of 321.83 K shares in the last 24 months. This purchase volume represents approximately $80.46 K in transactions.